Abstract
Advanced practice providers are relied on to recognize patients’ need for palliative care, which has supported improved quality of life and reduced aggressive treatments near the end of life in patients with solid tumors. Hematological malignancies have similar disease trajectories and symptom burdens as solid tumors, yet palliative care is underutilized in acute myeloid leukemia, which employs aggressive therapies for management. This systematic literature review examines the 3 studies of early palliative care in patients newly diagnosed with acute myeloid leukemia. There is a strong association between early palliative care and decreased chemotherapy use and decreased intensive care unit admissions at the end of life.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
